세계의 진통제 시장 : 약제 클래스별(오피오이드, 비오피오이드), 투여 경로별(경구, 국소, 정맥내, 경피, 직장), 지역별 - 시장 규모와 예측, COVID-19 영향 분석, 예측(-2028년)

Analgesics are drugs that are used to relieve pain. They work by blocking or reducing the transmission of pain signals to the brain, or by altering the brain's perception of pain. There are several different types of analgesics, including nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, opioids, and local anesthetics. It is important to use analgesics only as directed and to follow the instructions on the label. Overuse or misuse of analgesics can lead to serious health problems, including liver damage, kidney damage, and addiction. In 2022, the global analgesics market was valued at US$51.63 billion, and is probable to reach US$67.55 billion by 2028.

The older population also has more frequent pain and aching issues, which helps the sector thrive. Also, technological improvements in pharmaceutical businesses to develop better analgesic medications are projected to generate profitable opportunities for the analgesic market in the future years. Moreover, rise of chronic pain, the prevalence of major manufacturing businesses that manufacture and sell analgesic pharmaceuticals, rising demand for over-the-counter drugs, increasing demand for topical analgesics, and rising healthcare spending all contribute to the market's growth. The global analgesics market value is projected to grow at a CAGR of 4.6%, during the forecast period of 2023-2028.

Market Segmentation Analysis:

By Drug Class: According to the report, the global analgesics market is segmented into two drug class: Opioids and Non-Opioids. Opioids segment acquired majority of share in the market in 2022. An increase in the prevalence of chronic diseases such as tuberculosis, arthritis, and cancer is expected to fuel the opioid segment's expansion during the forecast period. Furthermore, the industry is expanding because to opioids' anti-inflammatory, analgesic, and antipyretic characteristics.

By Route of Administration: According to the report, the global analgesics market is bifurcated into five route of administration: Oral, Topical, Intravenous, Transdermal and Rectal. Oral segment acquired majority of share in the market in 2022, as its approval of numerous over-the-counter (OTC) analgesics which do not require medication, the oral variety is gaining economic momentum with increased sales. Whereas, Intravenous segment is expected to have the highest CAGR in the future as Intravenous analgesics are popular with patients who need immediate pain relief because they provide rapid and effective pain relief. Also, the penetration of topical analgesics has been steadily rising over the past decade as they provide less invasive-pain reduction. As a result, people with a more active lifestyle, e.g. sports, have a higher use rate. The proportion of topical compared to other analgesics is the highest in Asia Pacific.

By Region: The report provides insight into the analgesics market based on the geographical operations, namely North America, Europe, Asia Pacific, and Rest of the World. North America analgesics market enjoyed the highest market share in 2022, primarily due to the rise in demand for non-opioid medications, the presence of key players, and the expansion of R&D activities across the healthcare sector in the region. Many people in the US rely on inadequate analgesics to treat muscular injuries and diseases. Thus, surging the growth of the US analgesics market.

Asia Pacific analgesics market is slated to become the most lucrative zone for the analgesics medication industry. Drug, made by GlaxoSmithKline Asia Private Limited (GSKAP), is the popular analgesics brand in India. With over two million tablets sold every day in India and over 20 tablets sold per second, it falls under the non-prescription (OTC) category. This alone is a major influencer in the Asia Pacific analgesics industry, supported greatly by the widespread practice of self-medication. China has been increasing its healthcare spending, leading to an increase in the availability of healthcare facilities, including pain management services. This has led to an increase in the demand for analgesics in China.

Global Analgesics Market Dynamics:

Growth Drivers: The rising incidence of acute chronic diseases such heart disease, cancer, diabetes, stroke, and arthritis is a primary reason driving up demand for analgesics medications. A surge in the prevalence of these medical conditions increases the demand for painkillers, which in turn is driving the analgesics market growth. Further, the market is expected to increase due to increasing geriatric population, upsurge in healthcare expenditure, increased disposable income, upsurge in e-commerce sales, rising number of medical surgeries across the world, rising demand for strong agonists, etc.

Challenges: Analgesics are potent drugs that can be beneficial in pain management, but they also carry the danger of major adverse effects, such as addiction and overdose. Overdose and addiction can occur with any form of painkiller, but opioids, which are a type of powerful agonist analgesic, provide a particularly significant danger. The other challenge that analgesics market faces is increasing use of biologics and high cost of drug development, etc.

Trends: A major trend gaining pace in analgesics market is use of artificial intelligence in analgesics. AI might potentially be utilized to help build more effective and individualized pain treatment solutions in the context of the analgesics market. AI could be used, for example, to analyze data from patient medical records, such as information on their pain symptoms, medical history, and other things that may be contributing to their pain. More trends in the market are believed to augment the growth of analgesics market during the forecasted period include, surge in research & development in pharmaceutical sector strategic collaborations and technological development in the pharmaceutical industry, healthier lifestyles, etc.

Impact Analysis of COVID-19 and Way Forward:

The global analgesics market was impacted by the COVID-19 outbreak. The pandemic had a favorable impact on the market, since increased focus on personal health encouraged purchases of these medications. The demand for over-the-counter cold and cough medicines was already high, and nutritional supplements were likely to expand at a faster rate due to COVID-19. Furthermore, the European Medicines Agency has advised using non-steroidal anti-inflammatories (NSAIDs) such as ibuprofen and paracetamol to treat moderate COVID-19 symptoms at the lowest dose possible. Additionally, because geriatric population are more vulnerable to infection due to weakening immune systems and the lack of a vaccine or therapy, the number of older persons infected with COVID-19 was considerable. Hence, all these factors increased the demand of analgesics market during the pandemic period.

Competitive Landscape and Recent Developments:

Global analgesics market is fragmented. Haleon is the clear global leader in the analgesics category. Haleon's global market share has been broadly flat over the past decade, which has included a period of modest market share declines until 2020 and then a sharp improvement over the last two years post the Rx-to-OTC switch of Voltaren in the US. Key players of global analgesics market are:

Bayer AG

Sanofi S.A.

Pfizer Inc.

Abbott Laboratories

Reckitt Benckiser Group PLC.

Johnson & Johnson

Haleon PLC

TEVA Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Ltd.

Endo International Plc.

GlaxoSmithKline Plc

Eli Lilly and Company

The key players are constantly investing in strategic initiatives, such as new product launches, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance, in April 2022, Abbott introduced a new version of its NeuroSphere my Path, a digital health app. With this launch, the company aimed to facilitate healthcare professionals to more precisely track their patients as they trial Abbott neurostimulation instruments in order to address the chronic pain issue in them. Moreover, this launch would also complement the connected care technology portfolio of the company.

Table of Contents

1. Executive Summary

2. Introduction

• 2.1 Analgesics: An Overview
  • 2.1.1 Uses of Analgesics
• 2.2 Analgesics Segmentation: An Overview
  • 2.2.1 Analgesics Segmentation

3. Global Market Analysis

• 3.1 Global Analgesics Market: An Analysis
  • 3.1.1 Global Analgesics Market: An Overview
  • 3.1.2 Global Analgesics Market by Value
  • 3.1.3 Global Analgesics Market by Drug Class (Opioids and Non Opioids)
  • 3.1.4 Global Analgesics Market by Route of Administration (Oral, Topical, Intravenous, Transdermal and Rectal)
  • 3.1.5 Global Analgesics Market by Region (North America, Europe, Asia Pacific and Rest of the World)
• 3.2 Global Analgesics Market: Drug Class Analysis
  • 3.2.1 Global Analgesics Market by Drug Class: An Overview
  • 3.2.2 Global Opioids Analgesics Market by Value
  • 3.2.3 Global Non Opioids Analgesics Market by Value
• 3.3 Global Analgesics Market: Route of Administration Analysis
  • 3.3.1 Global Analgesics Market by Route of Administration: An Overview
  • 3.3.2 Global Oral Analgesics Market by Value
  • 3.3.3 Global Topical Analgesics Market by Value
  • 3.3.4 Global Intravenous Analgesics Market by Value
  • 3.3.5 Global Transdermal Analgesics Market by Value
  • 3.3.6 Global Rectal Analgesics Market by Value

4. Regional Market Analysis

• 4.1 North America Analgesics Market: An Analysis
  • 4.1.1 North America Analgesics Market: An Overview
  • 4.1.2 North America Analgesics Market by Value
  • 4.1.3 North America Analgesics Market by Route of Administration (Topical and Others)
  • 4.1.4 North America Topical and Others Analgesics Market by Value
  • 4.1.5 North America Analgesics Market by Region (The US, Canada and Mexico)
  • 4.1.6 The US Analgesics Market by Value
  • 4.1.7 Canada Analgesics Market by Value
  • 4.1.8 Mexico Analgesics Market by Value
• 4.2 Europe Analgesics Market: An Analysis
  • 4.2.1 Europe Analgesics Market: An Overview
  • 4.2.2 Europe Analgesics Market by Value
  • 4.2.3 Europe Analgesics Market by Route of Administration (Topical and Others)
  • 4.2.4 Europe Topical and Others Analgesics Market by Value
  • 4.2.5 Europe Analgesics Market by Region (Germany, UK, Italy, France, Spain and Rest of Europe)
  • 4.2.6 Germany Analgesics Market by Value
  • 4.2.7 UK Analgesics Market by Value
  • 4.2.8 Italy Analgesics Market by Value
  • 4.2.9 France Analgesics Market by Value
  • 4.2.10 Spain Analgesics Market by Value
  • 4.2.11 Rest of Europe Analgesics Market by Value
• 4.3 Asia Pacific Analgesics Market: An Analysis
  • 4.3.1 Asia Pacific Analgesics Market: An Overview
  • 4.3.2 Asia Pacific Analgesics Market by Value
  • 4.3.3 Asia Pacific Analgesics Market by Route of Administration (Topical and Others)
  • 4.3.4 Asia Pacific Topical and Others Analgesics Market by Value
  • 4.3.5 Asia Pacific Analgesics Market by Region (China, India, Japan, Australia and Rest of Asia Pacific)
  • 4.3.6 China Analgesics Market by Value
  • 4.3.7 India Analgesics Market by Value
  • 4.3.8 Japan Analgesics Market by Value
  • 4.3.9 Australia Analgesics Market by Value
  • 4.3.10 Rest of Asia Pacific Analgesics Market by Value
• 4.4 Rest of the World Analgesics Market: An Analysis
  • 4.4.1 Rest of the World Analgesics Market: An Overview
  • 4.4.2 Rest of the World Analgesics Market by Value

5. Impact of COVID-19

• 5.1 Impact of COVID-19
  • 5.1.1 Impact of COVID-19 on Analgesics Market
  • 5.1.2 Post COVID-19 Impact

6. Market Dynamics

• 6.1 Growth Drivers
  • 6.1.1 Rising Incidence of Acute Chronic Diseases
  • 6.1.2 Increasing Geriatric Population
  • 6.1.3 Upsurge in Healthcare Expenditure
  • 6.1.4 Increased Disposable Income
  • 6.1.5 Upsurge in E-Commerce Sales
  • 6.1.6 Rising Number of Medical Surgeries across the World
  • 6.1.7 Rising Demand for Strong Agonists
• 6.2 Challenges
  • 6.2.1 Risk of Overdose and Addiction
  • 6.2.2 Increasing Use of Biologics
  • 6.2.3 High Cost of Drug Development
• 6.3 Market Trends
  • 6.3.1 Use of Artificial Intelligence in Analgesics
  • 6.3.2 Surge in Research & Development in Pharmaceutical Sector
  • 6.3.3 Strategic Collaborations and Technological Development in The Pharmaceutical Industry
  • 6.3.4 Healthier Lifestyles
  • 6.3.5 Rx-to-OTC switches

7. Competitive Landscape

• 7.1 Global Analgesics Players by Market Share
• 7.2 Global Systemic Analgesics Players by Market Share
• 7.3 Global Topical Analgesics Players by Market Share
• 7.4 Western Europe Analgesics Players by Market Share
• 7.5 The US Topical Analgesics Players by Market Share
• 7.6 The US Systemic Analgesics Players by Market Share

8. Company Profiles

• 8.1 Bayer AG
  • 8.1.1 Business Overview
  • 8.1.2 Operating Segments
  • 8.1.3 Business Strategy
• 8.2 Sanofi S.A.
  • 8.2.1 Business Overview
  • 8.2.2 Operating Segments
  • 8.2.3 Business Strategy
• 8.3 Pfizer Inc.
  • 8.3.1 Business Overview
  • 8.3.2 Business Segments
  • 8.3.3 Business Strategy
• 8.4 Abbott Laboratories
  • 8.4.1 Business Overview
  • 8.4.2 Operating Segment
  • 8.4.3 Business Strategy
• 8.5 Reckitt Benckiser Group PLC
  • 8.5.1 Business Overview
  • 8.5.2 Operating Segments
  • 8.5.3 Business Strategy
• 8.6 Johnson & Johnson
  • 8.6.1 Business Overview
  • 8.6.2 Business Segment
  • 8.6.3 Business Strategy
• 8.7 Haleon PLC
  • 8.7.1 Business Overview
  • 8.7.2 Operating Segments
  • 8.7.3 Business Strategy
• 8.8 TEVA Pharmaceutical Industries Limited
  • 8.8.1 Business Overview
  • 8.8.2 Operating Segments
  • 8.8.3 Business Strategy
• 8.9 Sun Pharmaceutical Industries Ltd.
  • 8.9.1 Business Overview
  • 8.9.2 Operating Segments
  • 8.9.3 Business Strategy
• 8.10 Endo International Plc.
  • 8.10.1 Business Overview
  • 8.10.2 Operating Segment
  • 8.10.3 Business Strategy
• 8.11 GlaxoSmithKline Plc
  • 8.11.1 Business Overview
  • 8.11.2 Sales by Products
  • 8.11.3 Business Strategies
• 8.12 Eli Lilly and Company
  • 8.12.1 Business Overview
  • 8.12.2 Revenue by Products
  • 8.12.3 Business Strategy